Vision and Mission

Our Vision is to make the best tools, provide the best ideas and thoughts that can bring novel technologies and treatments to the market. 

Our ultimately goal is to provide improved or novel cancer treatment that can improve the health of those afflicted with this form of life threatening disease and ultimately offer a safe cure without notable side-effects.

Our Mission is to perform the tasks needed in order for us to qualify in partnerships with the healthcare community to market our technologies, and thereby improving patients' chances of survival in a safe and ethical manner.

Research and Technology

Scientific based research and technology development is not simply a matter of what one can achieve in the lab; it is a bridge between a complex matrix of disciplines where each piece in the puzzle is as important as the other.

At Giantcode Corporation we master this and therefore we can, for low-cost achieve the results we need by having access to the right expert, the needed technology and eventually fast-track clinical trials that will bring our innovations from being a good idea to becoming a good product. A leap that requires the ultimate of all individuals involved.

This is the spirit in our Research and Development program and the foundation for our value building for investors, partners, founders and patient

Scientific Commitment

As life-long scientist for some of us for more than two decades we are highly committed to the empirical nature of discovery and the peer reviewed principles of proving scientific results.

We believe in the scientific community where ideas are tested and tried. To the furthest possible extend without compromising our intellectual property right process; we do participate in the open scientific community at all levels of our scientific work.

Giantcode Corporation

Giantcode Corporation consist of associated companies in UK, USA, Singapore and Malaysia. The companies are active within biotechnology, pharmaceutical sale and drug development and related to that intellectual property right protection.